๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Levetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study

โœ Scribed by Angelo Labate; Eleonora Colosimo; Antonio Gambardella; Ugo Leggio; Roberta Ambrosio; Aldo Quattrone


Book ID
116880181
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
134 KB
Volume
15
Category
Article
ISSN
1059-1311

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Levetiracetam in tardive dyskinesia: An
โœ Spiros Konitsiotis; Sofia Pappa; Christos Mantas; Venos Mavreas ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 53 KB ๐Ÿ‘ 2 views

Levetiracetam (LEV), a novel antiepileptic drug, has demonstrated antidyskinetic effect in preclinical animal models of Parkinson's disease (PD) and in one open label study in PD patients with levodopa-induced dyskinesia. The acute antidyskinetic effects of LEV in patients with tardive dyskinesia we